Showing results (361-370 of 380) with videos related to
Sort By:
Pageof 38
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 21, 2023
Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate CancerNadia Benabdallah, Peng Lu, Diane S Abou, et al.Journal of the National Cancer Institute|January 31, 2025
NF2 loss-of-function and hypoxia drive radiation resistance in grade 2 meningiomasBhuvic Patel, Sangami Pugazenthi, Collin W English, et al.Angiology|November 20, 1998
Treatment of severe intermittent claudication with PGE1--a short-term vs a long-term infusion plan--a 20 week, European randomized trial--analysis of efficacy and costsG Belcaro, G Laurora, A N Nicolaides, et al.Obesity (Silver Spring, Md.)|November 9, 2024
Relationships between abdominal adipose tissue and neuroinflammation with diffusion basis spectrum imaging in midlife obesityMahsa Dolatshahi, Paul K Commean, Farzaneh Rahmani, et al.Theranostics|May 14, 2025
Pilot first-in-human CCR2 PET/CT to detect abdominal aortic aneurysm wall instabilitySantiago Elizondo-Benedetto, Deborah Sultan, Ryan Wahidi, et al.Angiology|August 26, 2000
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European StudyG Belcaro, A N Nicolaides, G Cipollone, et al.Journal of Alzheimer'S Disease : JAD|June 6, 2026
Abdominal adiposity and Alzheimer's disease imaging markers across sex and race at midlifeMahsa Dolatshahi, Paul K Commean, Mahshid Naghashzadeh, et al.Angiology|August 26, 2000
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trialG Belcaro, A N Nicolaides, G Agus, et al.Angiology|June 6, 2003
Foam-sclerotherapy, surgery, sclerotherapy, and combined treatment for varicose veins: a 10-year, prospective, randomized, controlled, trial (VEDICO trial)G Belcaro, M R Cesarone, A Di Renzo, et al.Diabetes|September 28, 2005
Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9George R Lankas, Barbara Leiting, Ranabir Sinha Roy, et al.Pageof 38